Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Olfactory transduction | R-HSA-9751605 | map04740 | nicergoline | 34040 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | nicergoline | 34040 | drug-path |
Asthma | R-HSA-444620 | map05310 | nicergoline | 34040 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | nicergoline | 34040 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | nicergoline | 34040 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | nicergoline | 34040 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | nicergoline | 34040 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | nicergoline | 34040 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | nicergoline | 34040 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | nicergoline | 34040 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | nicergoline | 34040 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | gallamine triethiodide | 6172 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | gallamine triethiodide | 6172 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | aminophenazone | 54766 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | aminophenazone | 54766 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | aminophenazone | 54766 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | aminophenazone | 54766 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | aminophenazone | 54766 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | aminophenazone | 54766 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | aminophenazone | 54766 | drug-path |